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S tandards are the basis of technology:they allow rigorous description andexact measurement of properties, reli-
able reproducibility and a common
“language” that enables different communi-
ties to work together. Molecular biology was
in part created by physicists; yet, the field
did not inherit the focus on the quantitation,
the definition of system boundaries and the
robust, unequivocal language that is charac-
teristic of the other natural sciences.
However, synthetic biology (SynBio)
increasingly requires scientific, technical,
operational and semantic standards for the
field to become a full-fledged engineering
discipline with a high level of accuracy in
the design, manufacturing and performance
of biological artefacts. Although the benefits
of adopting standards are clear, the commu-
nity is still largely reluctant to accept them,
owing to concerns about adoption costs and
losses in flexibility.
......................................................
“. . . Synthetic Biology (SynBio)
increasingly requires scientific,
technical, operational and
semantic standards for the
field to become a full-fledged
engineering discipline . . .”
......................................................
What standards are good for
In science and technology, the terms stan-
dard and standardisation describe different
things: shared semantic and graphical
languages for annotating the nature and the
properties of systems and their components;
the definition of units of relevant properties
and parameters along with methods to
calculate them; specifications of properties
and arrangements for the physical assembly
of the components of a system; and unam-
biguous protocols for the construction of
objects. Such standards enable an abstract
and precise description of a system with a
suitable—also standardised—quantitative
language or equivalent methods of
representation.
Beyond their important role in the natural
sciences, standards were also one of the key
drivers for the industrial revolution as they
enabled a seamless integration of product
design, fabrication of its components and
the final assembly—let alone tracing parts
and helping to sort out matters of safety and
intellectual property. Standards are for
instance imperative for designing electronic
circuits built from well-defined, universal
simple components, such as resistors, diodes
and transistors, or for software engineering
that uses precompiled modules and func-
tions. Standards enabled the rapid rise of the
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personal computer industry in the 1980s and
1990s by interlinking standard components
such as hard discs, memory or keyboards
through standardised interfaces and
protocols.
......................................................
“. . . standards were also one
of the key drivers for the indus-
trial revolution as they enabled
a seamless integration of
product design, fabrication of
its components and the final
assembly. . .”
......................................................
From software to nuts and bolts, the
concept of a universally usable toolbox of
parts to assemble more complex systems is
typical for every discipline of engineering:
electronics, software, mechanical design,
architecture, chemical synthesis and so on.
Standards enable people to work together
through interoperability, coordination of
labour, reproducibility and reuse of other
people’s efforts and achievements.
Standards must be reliable, robust and
affordable, but, first and foremost, they must
be agreed on by their users. Indeed, stan-
dardisation—the process of implementing
and developing technical standards—
requires the consensus of many different
parties, such as private and public compa-
nies, organisations and policy makers. Stan-
dardisation can be driven by public
acceptance/market forces (de facto stan-
dards), directly ordained by law (de jure
standards) or, most commonly, arise from
the combination of legal/technical require-
ments and recognition by potential operators
since, in general, the broader the applicabil-
ity of a format, the greater its market [1].
Standards in the life sciences
That said, the core standardisation process in
many scientific and engineering disciplines
took place decades to centuries ago, but it is
still in its infancy in the life sciences. Interest-
ingly, it is still a bottleneck for even well-
developed technologies: smartphones, for
instance, still lack standard key components
such as batteries or electric charger cables (see
e.g. https://ec.europa.eu/info/law/better-re
gulation/initiatives/ares-2018-6427186_en).
In this context, the conceptual frame of
synthetic biology aims to making biology
easier to engineer by applying principles
such as modularity, orthogonality, chain
production and reproducibility. Moreover,
the rapid advances in wet and computa-
tional tools for genome editing, metabolic
design and in silico modelling are opening
new opportunities for genetic programming
that could not have been anticipated even
just a few years ago, and allow engineers to
tackle increasingly complex engineering
objectives. The growing demand for scaling
up such technologies raises the issue of what
is needed to make them work at an indus-
trial scale [2]. Following the path of other
branches of engineering, the establishment
of standards appears among the key objec-
tives of contemporary SynBio—and eventu-
ally of the life sciences as a whole—as a
prerequisite for applications such as biore-
mediation, biomedicine, bioenergy, novel
chemicals, innovative materials and cellular
factories.
Although standards in SynBio have
contributed to successes such as the synthe-
sis of artemisinin or morphine (both in
yeast), the problem of defining common
standards is still far from being resolved.
The reusability patterns of the iGEM parts
database [3], the context dependence of
biological components [4], the variable
behaviour among strains, genetic stability or
even the contested philosophical analogy
between cells and machines are by no
means solved issues at this point. However,
there is no doubt that even partial progress
on standardisation would have major conse-
quences for bioengineering.
One bottleneck is the widespread and
incorrect assumption among many
researchers in the life sciences that stan-
dards may increase interoperability but
necessarily limit flexibility—which is obvi-
ously important for any creative research.
Rather, good standards will increase
people’s flexibility and creativity because it
will make it easier for them to achieve their
scientific objectives. A separate challenge is
identifying specific systems and operations
that need to be standardised, and then navi-
gating the minefield of personal interests
that typically inhibit agreement on a given
format or language. As Murray Gell-Mann
quipped, “a scientist would rather use some-
one else’s toothbrush than someone else’s
nomenclature”. Scientists and engineers will
adopt standards only when they add value
to their efforts to overcome the often steep
costs of adoption.
Standards for engineering biology
While a number of SynBio standards have
already been developed and await adoption
by the broader community of users [5],
others touch on core biological questions
that are by no means solved from a scientific
point of view. There is a legitimate concern
that we still need to know more fundamen-
tal facts before we can describe engineered
biosystems with a formal, unequivocal
language. One typical case involves the
design of genetic circuits, an archetypal
product of SynBio endeavours. Habitual
practices include directly transplanting
toolkit for building electronic logic gates and
related information-processing devices into
the biological domain. However, one must
be honest about how far these abstractions
and their accompanying theoretical frame-
work reflect biological reality. Boolean logic
relies on values that are either true or false.
In electronics, this is readily implemented
using voltage levels that are separated by a
larger amount than the expected noise to
faithfully represent the state of the gate. In
contrast, biological implementations of
circuits tend to have a much higher noise-to-
signal ratio, which makes it difficult to effec-
tively distinguish true and false states and
strongly limits the design of logic circuits.
One way to alleviate this problem is by
redesigning regulatory components to
behave more digitally, but ultimately, we
may need to revisit information processing
in/by biological systems with other formal-
isms, either existing or yet to be developed,
that go beyond Boolean logic [6].
......................................................
“Scientists and engineers will
adopt standards only when
they add value to their efforts
to overcome the often steep
costs of adoption.”
......................................................
The same theory/implementation conun-
drum might be true for biological metrology,
one of the main tenets of SynBio. Electronic
circuits crucially rely on a clear definition of
potential and current, their description in
volts and amperes, and methods to measure
these. By the same token, it is difficult to
think about genetic circuits without robust
measures of signal transmission through the
regulation of gene expression or other core
cellular processes. The concepts of RNA
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polymerase per second (PoPS; [7]) and ribo-
some per second (RiPS) as biological coun-
terparts of current were conceptualised early
in the history of SynBio. Alas, very little has
been done to further develop these units as
practicable indicators of genetic circuit
performance, perhaps due to the difficulties
of measuring them accurately.
These examples showcase how developing
standards for biological engineering still
requires addressing a number of core scien-
tific and technological gaps that have been left
behind in the ongoing frenzy of application-
focused development. Yet, such unsolved
issues may strike back when the field contin-
ues to move from largely academic endea-
vours towards industrial realisation.
......................................................
“. . .developing standards for
biological engineering still
requires addressing a number
of core scientific and technolog-
ical gaps that have been left
behind in the ongoing frenzy of
application-focused develop-
ment.”
......................................................
Key actors in the standards
conversation
International discussions about SynBio stan-
dards, mostly with US and EU stakeholders,
have been going on since before 2010. Under
the umbrella of the BIOROBOOST Project
(http://standardsinsynbio.eu), the conversa-
tion now incorporates key actors of SynBio
from Europe, North America and Asia. Much
of the discussions deal with identifying key
challenges for the development, promulga-
tion and adoption of standards, and identify-
ing stakeholders in academia, industry,
research centres and politics.
The most conspicuous technical chal-
lenges include standardising simple biologi-
cal parts, devices and circuits, chassis,
metrology, descriptive languages (including
graphical representations) and software
tools. But the complexity of the endeavour
also asks for the creation of a network of
SynBio practitioners that share and evolve
these standards together. While this is remi-
niscent of earlier Computational Modeling in
Biology Network (COMBINE, http://co.mb
ine.org/), the focus of these SynBio
networks needs to go beyond academic
interests to include industry and commerce,
and to develop strategies for educating a
new generation of synthetic biologists who
routinely use standards.
From the regulatory, technical and soci-
etal point of view, the challenge is complex.
For example, there are practical questions
such as the level of detail required in a given
biological standard, which can go from light
to very deep. As indicated above, standard
is an umbrella concept, which includes a
number of different approaches to harmoni-
sation. These range from agreeing on metro-
logy units and best practices to measure
them, to developing standardised functional
chassis—specific, formatted biological hosts
for specific applications—to data formats, to
safety criteria for approval by regulatory
agencies and to ISO-approved reports and
technical specifications.
It is necessary to distinguish between
biological standards that could be similar to
physics and engineering counterparts, such as
the PoPS or RiPS units discussed above, and
standard operating procedures (SOPs), which
help users to carry out routine operations
with efficiency, consistent quality and perfor-
mance, and are compliant with regulations.
For instance, the composition and preparation
of the M9 medium would be an SOP, while
the metrics for calculating containment of a
given SynBio agent when released in the envi-
ronment could become a biological standard.
There are, of course, many grey zones
between these two—for instance, formats for
enabling communication between unrelated
software, cloning methods, CRISPR-based
editing and so on—that will hopefully be
solved through conversations between stake-
holders in the various forums just mentioned.
The question remains, however, whether the
wider community of potential users will see
the value of adopting standards in their daily
practice. Today, SynBio and systems biology
practitioners are widely using the Synthetic
Biology Open Language SBOL [8] and SBOL
visual for describing vectors and constructs
[9], and there is a great consensus on the
need to go beyond the state of the art and
further advance towards the standardisation
of biological systems [5,10].
Stages of adoption
Is there a take-home lesson from the history
of technology adoption that we can learn
from for popularising biological standards?
In fact, the trajectory of acceptance in the
realm of engineering typically involves
several stages: from an innovator phase to
adoption by even the most recalcitrant
laggards (Fig 1). Using this frame, it seems
that most of the SynBio’s standards develop-
ments are still in the innovator phase.
Many developments, even if critical for
the early years in SynBio, never left the
innovator state and are now outdated;
advances in cloning and DNA synthesis have
for instance replaced BioBricks. Others, such
as SBOL [8] or the Standard European
Vector Architecture (SEVA; [9]) are increas-
ingly successful as interim formats in the
early adopter stage. Yet, these may or may
not become generally adopted depending on
success stories and potential alternative
scientific and technical solutions. Such
progress will be determined by the combina-
tion of a bottom-up demand for interoper-
ability and collaboration and a top-down
implementation and enforcement by official
agencies. Journal editors also have a role to
play as well as reviewers of journal articles
and grant proposals in insisting on the use
of standards to improve reproducibility and
reuse. Generally, it is important to realise
that standards are ultimately social
constructs to represent norms, objects or
procedures, and that they become accepted
by a group of individuals for practical
reasons.
......................................................
“. . . standards are ultimately
social constructs to represent
norms, objects or procedures,
and that they become accepted
by a group of individuals for
practical reasons.”......................................................
Low-hanging fruits
Despite the difficulties, it should be possible
to come up with science-based standardisa-
tion proposals in SynBio that work across
the biological, the digital and the social
realms. The already existing ones at hand
involve simple biological parts: devices such
as promoters and other regulatory nodes
and simple circuits—for instance, inverters,
basic gates—such as those deposited in the
repository of biological parts and other
curated collections. The next stage involves
definition and adoption of SynBio chassis
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other than laboratory bacteria or yeast
strains. Not every species or strain that can
host recombinant DNA can be considered a
chassis, and this effort requires establish-
ment of a map of requirements and func-
tional relationships between industrially
relevant practical applications and different
biological platforms. Finally, standardisation
would need to address the issue of metro-
logy through the gene expression flow
including fundamental units and the tech-
nologies and references to measure them, as
well as computational language and soft-
ware tools for easing collaborations between
different actors. The main efforts to collect
such low-hanging fruits would be greatly
facilitated by biofoundries with good
connections to policy makers with the objec-
tive of making the whole endeavour more
appealing for the industrial sector.
......................................................
“.. the key to success is the
merger of technical consistency
and scientific soundness with
legal requirements and consen-
sus among end users.”
......................................................
The academic community cannot be a
mere observer of these developments. In
fact, there is much to do for endowing
biological standards with a solid scientific
basis, including the definition of each level
of biological complexity amenable to stan-
dardisation. But the role in promoting
standards is not only technical. There is
ample room for networks of practitioners
involving industrial players, who can
provide information on how biological prop-
erties and processes could improve product
development, manufacturability and
consumer confidence. This could create a
framework for identifying and monitoring
standardisation requirements and maintain-
ing an evolving list of scientific and indus-
trial priorities. Ideally, such priority lists
should also be considered by funding bodies
to help in developing and driving adoption
of standards. Relevant regulatory bodies
should be involved to adapt or ease rules on
the management of GMOs and/or SynBio
agents. The same academic–industrial
networks could also strengthen ongoing
public outreach and citizen involvement to
help overcoming the negative perception of
genetic engineering in general.
In sum, we argue that the promise of
SynBio for the benefit of global society
and industry will only be met if significant
advances are achieved on the standardisa-
tion front. To this end, it is not only
essential to overcome national/political
barriers and particular interests of given
research groups, but also to gather key
players in a permanent forum with the
aim of making biological standards one of
the ingredients of the 4th Industrial Revolu-
tion. Standards in biology will be used
provided that they have intrinsic properties
such as robustness, ease of use and
context independence. But the key to
success is the merger of technical
consistency and scientific soundness with
legal requirements and consensus among
end users. This goes beyond the realm of
research and tackles sociological and
cultural issues that have been traditionally
alien to the conversation. If this can be
achieved, the benefits for SynBio and for
society at large will be great.
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